Praxis Precision Medicines, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 26.88 million compared to USD 41.17 million a year ago. Basic loss per share from continuing operations was USD 2.97 compared to USD 12.98 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.78 USD | -2.62% | -10.56% | +118.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.94% | 835M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- PRAX Stock
- News Praxis Precision Medicines, Inc.
- Praxis Precision Medicines, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023